From the Editor-in-Chief

Paying attention to the social determinants of health will promote greater equity in cancer outcomes for all.

by William G. Nelson, MD, PhD

Forward Look

The Clinical Treatment Act aims to include more Medicaid recipients.

by Jen Tota McGivney

Forward Look

Fear of discrimination may lead to lower screening rates.

by Tara Santora

Policy Matters

The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

Research describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups.

by Marci A. Landsmann

At a symposium held during a virtual meeting of cancer researchers, panelists discussed the disproportionate impact COVID-19 has had on Black and Latino Americans, as well as members of other minority groups.

by Kevin McLaughlin

NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”

by Kevin McLaughlin

POLICY MATTERS

Cancer outcomes are changing for the better, but advances are not affecting all patients equally.

by Brian Rivers, PhD

Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

by Sue Rochman

FORWARD LOOK

Programs aim to increase awareness of benefits.

by Sue Rochman